Skip to main content
Equibles

CAPITAL INTERNATIONAL LTD /CA/

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1065350 LOS ANGELES, CA
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$48,348,717
+$5,537,142 QoQ
Shares Held
97,334
+1.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
#174
of 1,746 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL INTERNATIONAL LTD /CA/ holds $127,577,689 across 7 Biotechnology names. VRTX ranks #1 (37.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		97,334 $48,348,717
2 RPRX
Royalty Pharma plc
 579,801 $32,509,442
3 ONC
BeOne Medicines Ltd.
 77,161 $21,988,570
4 ALNY
Alnylam Pharmaceuticals, Inc.
 29,166 $8,779,840
5 REGN
Regeneron Pharmaceuticals, Inc.
 13,665 $8,520,674
6 ASND
Ascendis Pharma A/S
 16,394 $4,372,607
7 CRSP
CRISPR Therapeutics AG
 56,066 $3,057,839

All Filings in VRTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $48,348,717 97,334
2026-03-31 $42,811,575 95,874
2025-12-31 $43,346,656 95,612
2025-09-30 $47,500,840 121,287
2025-06-30 $56,810,636 127,607
2025-03-31 $54,564,551 112,546
2024-12-31 $44,526,941 110,571
2024-09-30 $46,324,293 99,605
2024-06-30 $47,092,767 100,471
2024-03-31 $41,615,403 99,556
2023-12-31 $34,535,195 84,876
2023-09-30 $28,340,462 81,499
2023-06-30 $28,237,258 80,240
2023-03-31 $21,964,474 69,713
2022-12-31 $18,902,094 65,455
2022-09-30 $20,513,909 70,850
2022-06-30 $17,856,186 63,367
2022-03-31 $16,507,918 63,256
2021-12-31 $18,356,583 83,591
2021-09-30 $13,342,141 73,555
2021-06-30 $17,345,825 86,028
2021-03-31 $17,166,272 79,884
2020-12-31 $19,181,118 81,159
2020-09-30 $22,381,870 82,250
2020-06-30 $19,168,878 66,029
2020-03-31 $14,996,798 63,025